Home/Pipeline/Resect

Resect

Real-time Surgical Margin Assessment in Cancer Surgery

Pre-clinicalActive

Key Facts

Indication
Real-time Surgical Margin Assessment in Cancer Surgery
Phase
Pre-clinical
Status
Active
Company

About Olfactomics

Olfactomics is pioneering next-generation volatile organic compound (VOC) analysis by combining its best-in-class differential mobility spectrometry (DMS) hardware with advanced machine learning analytics. The company operates in two primary verticals: industrial applications, such as battery safety and material quality control, and medical diagnostics, with a focus on real-time tissue analysis during cancer surgery. Founded by surgeons and engineers, Olfactomics is translating its platform technology into specific products like IonVision for industrial use and Resect for surgical margin assessment, positioning itself at the intersection of analytical chemistry, AI, and precision medicine.

View full company profile

Therapeutic Areas